TuHURA Biosciences, Inc.
NASDAQ:HURABiotechnology
Healthcare
$1.37 +6.37%
+$0.14 today
- Market cap
- $87.31M
- Beta
- 0.01
- P/E (TTM)
- -4.6
- EPS (TTM)
- -$0.52
52W Low $0.41High $3.90
Volume 0.19M
Average 0.85M
HURA Pre-Tax Margin
Income before tax as a percentage of revenue.
No reported Pre-Tax Margin figures are available to summarize.
Pre-Tax Margin history
Percent of revenue · from the income statement
No Pre-Tax Margin data reported for this period type.
Pre-Tax Margin vs competitors
How HURA compares with its peers on the latest reported figures
HURA Competitors Peer median
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 50.5% | +246.6 pp | +232.6 pp | |
| LTM Mar 2026 | 28.3% | +184.8 pp | +110.4 pp | |
| LTM Mar 2026 | -468.0% | +96.8 pp | +177.7 pp | |
IRDOpus Genetics, Inc. | LTM Mar 2026 | -892.4% | -462.9 pp | -395.0 pp |
| LTM Mar 2026 | -4088.8% | — | — | |
| FY2025 | -130000.0% | -80745.7 pp | -127273.3 pp | |
| FY2025 | — | — | — | |
| FY2025 | — | — | — | |
| FY2025 | — | — | — | |
| Peer median (excluding HURA) | -680.2% | +96.8 pp | +110.4 pp | |
Competitors are the stored peer set for HURA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 60K | 60K | 55K | 0 | 0 |
| Gross Profit | (60K) | (60K) | (55K) | 0 | 0 |
| Gross Margin | — | — | — | — | — |
| Research & Development | 15.17M | 9.31M | 2.66M | 13.34M | 20.53M |
| Selling, General & Admin | 7.45M | 5.43M | 5.73M | 3.87M | 7.58M |
| Operating Expenses | 22.62M | 14.74M | 8.4M | 17.65M | 31.8M |
| Depreciation & Amortization | 60K | 60K | 55K | 116.71K | 71.27K |
| EBITDA | (21.97M) | (14.59M) | (8.27M) | (17.43M) | (29.36M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (22.68M) | (14.8M) | (8.45M) | (17.65M) | (31.8M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 0 | 57.35K | 89.67K | 361.63K | 136.23K |
| Interest Expense | 629.29K | 0 | 18.69K | 4.14M | 625.28K |
| Other Income / Expenses | 21K | 147K | 131K | (4.03M) | 1.74M |
| Income Before Tax | (22.66M) | (14.65M) | (8.32M) | (21.68M) | (30.06M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (22.66M) | (14.65M) | (8.32M) | (21.68M) | (30.06M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | (903.04) | (324.48) | (11.29) | (1.21) | (0.63) |
| EPS (Diluted) | (903.04) | (324.48) | (11.29) | (1.21) | (0.63) |
| Weighted Avg Shares | 27.83K | 46.29K | 752.91K | 18.66M | 47.93M |
| Weighted Avg Shares (Diluted) | 27.83K | 46.29K | 752.91K | 18.66M | 47.93M |
TuHURA Biosciences, Inc.
NASDAQ:HURA
Intrinsic Alpha fair value
Locked
Current Price
$1.37
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.